Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical trials. Nail-biting time for trials of COX-2 drugs.

× No keyword cloud information.

11 in total

1. Microsomal prostaglandin E synthase-1 inhibits PTEN and promotes experimental cholangiocarcinogenesis and tumor progression.

Authors: Dongdong Lu; Chang Han; Tong Wu
Journal: Gastroenterology Date: 2011-02-24 Impact factor: 22.682

2. Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression.

Authors: Lu Yao; Chang Han; Kyoungsub Song; Jinqiang Zhang; Kyu Lim; Tong Wu
Journal: Cancer Res Date: 2015-02-17 Impact factor: 12.701

3. Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?

Authors: Bruno P Imbimbo; Vincenzo Solfrizzi; Francesco Panza
Journal: Front Aging Neurosci Date: 2010-05-21 Impact factor: 5.750

Review 4. Interdisciplinary review for correlation between the plant origin capsaicinoids, non-steroidal antiinflammatory drugs, gastrointestinal mucosal damage and prevention in animals and human beings.

Authors: Gyula Mózsik; Tibor Past; Omar M E Abdel Salam; Mónika Kuzma; Pál Perjési
Journal: Inflammopharmacology Date: 2009-06-26 Impact factor: 4.473

Review 5. The role of inflammation in CNS injury and disease.

Authors: Sian-Marie Lucas; Nancy J Rothwell; Rosemary M Gibson
Journal: Br J Pharmacol Date: 2006-01 Impact factor: 8.739

6. Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axis.

Authors: D Lu; C Han; T Wu
Journal: Oncogene Date: 2011-07-11 Impact factor: 9.867

7. Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors.

Authors: Randall E Harris; Joanne Beebe-Donk; Galal A Alshafie
Journal: BMC Cancer Date: 2006-01-30 Impact factor: 4.430

8. 15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1.

Authors: D Lu; C Han; T Wu
Journal: Oncogene Date: 2013-04-01 Impact factor: 9.867

9. Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors.

Authors: Randall E Harris; Joanne Beebe-Donk; Galal A Alshafie
Journal: BMC Cancer Date: 2008-08-14 Impact factor: 4.430

10. Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study.

Authors: Randall E Harris; Joanne Beebe-Donk; Galal A Alshafie
Journal: Int J Biol Sci Date: 2007-06-13 Impact factor: 6.580